Recent developments in Missouri have led to the suspension of sales for the kratom product known as 7-OH. Authorities in various settlements, citing health concerns and a lack of regulation surrounding kratom, have decided to halt distribution to protect consumers. 7-OH, a metabolite of mitragynine, has gained popularity for its potential pain-relieving and mood-enhancing effects. However, the absence of robust scientific research on its safety and efficacy has raised alarms among health officials.
Critics have pointed out that without proper oversight, consumers may be exposed to harmful dosages or contaminated products. The Missouri restrictions come amidst a growing national conversation about kratom, with some states implementing similar bans while others consider it a beneficial herbal alternative. As public interest continues to rise, the future of 7-OH and similar substances hangs in the balance, raising questions about regulation, consumer safety, and the legal status of kratom in the United States.
For more details and the full reference, visit the source link below:
Read the complete article here: https://www.stl.news/missouri-settlements-halt-7-oh-kratom-sales/